{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T14:00:24Z","timestamp":1772805624116,"version":"3.50.1"},"reference-count":114,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2021,2,25]],"date-time":"2021-02-25T00:00:00Z","timestamp":1614211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan","award":["26461703"],"award-info":[{"award-number":["26461703"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Itch or pruritus is the hallmark of atopic dermatitis and is defined as an unpleasant sensation that evokes the desire to scratch. It is also believed that itch is a signal of danger from various environmental factors or physiological abnormalities. Because histamine is a well-known substance inducing itch, H1-antihistamines are the most frequently used drugs to treat pruritus. However, H1-antihistamines are not fully effective against intractable itch in patients with atopic dermatitis. Given that intractable itch is a clinical problem that markedly decreases quality of life, its treatment in atopic dermatitis is of high importance. Histamine-independent itch may be elicited by various pruritogens, including proteases, cytokines, neuropeptides, lipids, and opioids, and their cognate receptors, such as protease-activated receptors, cytokine receptors, Mas-related G protein-coupled receptors, opioid receptors, and transient receptor potential channels. In addition, cutaneous hyperinnervation is partly involved in itch sensitization in the periphery. It is believed that dry skin is a key feature of intractable itch in atopic dermatitis. Treatment of the underlying conditions that cause itch is necessary to improve the quality of life of patients with atopic dermatitis. This review describes current insights into the pathophysiology of itch and its treatment in atopic dermatitis.<\/jats:p>","DOI":"10.3390\/biomedicines9030229","type":"journal-article","created":{"date-parts":[[2021,2,25]],"date-time":"2021-02-25T05:20:08Z","timestamp":1614230408000},"page":"229","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Intractable Itch in Atopic Dermatitis: Causes and Treatments"],"prefix":"10.3390","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9039-0644","authenticated-orcid":false,"given":"Yoshie","family":"Umehara","sequence":"first","affiliation":[{"name":"Atopy (Allergy) Research Center, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chanisa","family":"Kiatsurayanon","sequence":"additional","affiliation":[{"name":"Institute of Dermatology, Department of Medical Services, Ministry of Public Health, Bangkok 10400, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Valentin","family":"Trujillo-Paez","sequence":"additional","affiliation":[{"name":"Atopy (Allergy) Research Center, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panjit","family":"Chieosilapatham","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ge","family":"Peng","sequence":"additional","affiliation":[{"name":"Atopy (Allergy) Research Center, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hainan","family":"Yue","sequence":"additional","affiliation":[{"name":"Atopy (Allergy) Research Center, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9566-2458","authenticated-orcid":false,"given":"Hai Le Thanh","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Atopy (Allergy) Research Center, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pu","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Xijing Hospital, Fourth Military Medical University, Xi\u2019an 710032, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ko","family":"Okumura","sequence":"additional","affiliation":[{"name":"Atopy (Allergy) Research Center, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideoki","family":"Ogawa","sequence":"additional","affiliation":[{"name":"Atopy (Allergy) Research Center, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0588-8315","authenticated-orcid":false,"given":"Fran\u00e7ois","family":"Niyonsaba","sequence":"additional","affiliation":[{"name":"Atopy (Allergy) Research Center, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan"},{"name":"Faculty of International Liberal Arts, Juntendo University, Tokyo 113-8421, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,2,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"448","DOI":"10.18176\/jiaci.0519","article-title":"A multicenter study on the prevalence of clinical patterns and clinical phenotypes in adult atopic dermatitis","volume":"30","author":"Nettis","year":"2020","journal-title":"J. Investig. Allergol. Clin. Immunol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s13555-020-00459-8","article-title":"The economic and psychosocial comorbidity burden among adults with moderate-to-severe atopic dermatitis in Europe: Analysis of a cross-sectional survey","volume":"11","author":"Girolomoni","year":"2021","journal-title":"Dermatol. Ther."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/978-3-319-64804-0_3","article-title":"Atopic Dermatitis: Pathophysiology","volume":"1027","author":"Tarbox","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.alit.2016.10.005","article-title":"Exacerbating factors of itch in atopic dermatitis","volume":"66","author":"Murota","year":"2017","journal-title":"Allergol. Int."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2340\/00015555-1188","article-title":"Psychoneuroimmunology of psychological stress and atopic dermatitis: Pathophysiologic and therapeutic updates","volume":"92","author":"Feramisco","year":"2012","journal-title":"Acta Derm. Venereol."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Bonamonte, D., Filoni, A., Vestita, M., Romita, P., Foti, C., and Angelini, G. (2019). The role of the environmental risk factors in the pathogenesis and clinical outcome of atopic dermatitis. Biomed. Res. Int., 2019.","DOI":"10.1155\/2019\/2450605"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1001\/archderm.135.12.1522","article-title":"An evidence-based review of the efficacy of antihistamines in relieving pruritus in atopic dermatitis","volume":"135","author":"Klein","year":"1999","journal-title":"Arch. Dermatol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/nrn1950","article-title":"The neurobiology of itch","volume":"7","author":"Ikoma","year":"2006","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.cell.2009.09.028","article-title":"Cellular and molecular mechanisms of pain","volume":"139","author":"Basbaum","year":"2009","journal-title":"Cell"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.alit.2016.10.003","article-title":"The molecular and cellular mechanisms of itch and the involvement of TRP channels in the peripheral sensory nervous system and skin","volume":"66","author":"Kittaka","year":"2017","journal-title":"Allergol. Int."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1111\/bph.12569","article-title":"TRP channels in the skin","volume":"171","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1111\/bph.12532","article-title":"Transient receptor potential ion channels in primary sensory neurons as targets for novel analgesics","volume":"171","author":"Andreou","year":"2014","journal-title":"Brit. J. Pharmacol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/S0140-6736(03)12570-6","article-title":"Itch","volume":"361","author":"Yosipovitch","year":"2003","journal-title":"Lancet"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1212\/WNL.62.2.212","article-title":"Painful stimuli evoke itch in patients with chronic pruritus: Central sensitization for itch","volume":"62","author":"Ikoma","year":"2004","journal-title":"Neurology"},{"key":"ref_15","unstructured":"Carstens, E., and Akiyama, T. (2014). Peripheral Neuronal Mechanism of Itch: Histamine and Itch. Itch: Mechanisms and Treatment, CRC Press."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"533","DOI":"10.2332\/allergolint.13-RA-0675","article-title":"The role of histamine H1 and H4 receptors in atopic dermatitis: From basic research to clinical study","volume":"63","author":"Ohsawa","year":"2014","journal-title":"Allergol. Int."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1440-1592.2004.00358.x","article-title":"Scratching behavior in NC\/Nga mice with dermatitis: Involvement of histamine-induced itching","volume":"53","author":"Hashimoto","year":"2004","journal-title":"Allergol. Int."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/jid.2013.351","article-title":"Histamine H(4) receptor antagonists ineffective against itch and skin inflammation in atopic dermatitis mouse model","volume":"134","author":"Kamo","year":"2014","journal-title":"J. Investig. Dermatol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/978-3-662-44605-8_13","article-title":"Protease-Activated Receptors and Itch","volume":"Volume 226","author":"Akiyama","year":"2015","journal-title":"Handbook of Experimental Pharmacology"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1111\/j.1365-2133.1997.tb03927.x","article-title":"Quantitative analysis of tryptase- and chymase-containing mast cells in atopic dermatitis and nummular eczema","volume":"136","author":"Naukkarinen","year":"1997","journal-title":"Br. J. Dermatol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1600-0625.2007.00562.x","article-title":"Human tissue kallikrein expression in the stratum corneum and serum of atopic dermatitis patients","volume":"16","author":"Komatsu","year":"2007","journal-title":"Exp. Dermatol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1254\/jphs.08200SC","article-title":"Activation of proteinase-activated receptors induces itch-associated response through histamine-dependent and -independent pathways in mice","volume":"108","author":"Tsujii","year":"2008","journal-title":"J. Pharmacol. Sci."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1254\/jphs.08332FP","article-title":"Involvement of tryptase and proteinase-activated receptor-2 in spontaneous itch-associated response in mice with atopy-like dermatitis","volume":"109","author":"Tsujii","year":"2009","journal-title":"J. Pharmacol. Sci."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.1523\/JNEUROSCI.0716-08.2008","article-title":"Cowhage-evoked itch is mediated by a novel cysteine protease: A ligand of protease-activated receptors","volume":"28","author":"Reddy","year":"2008","journal-title":"J. Neurosci."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/j.1365-2133.2010.09862.x","article-title":"Plant cysteine proteases that evoke itch activate protease-activated receptors","volume":"163","author":"Reddy","year":"2010","journal-title":"Br. J. Dermatol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/bjp.2008.172","article-title":"Evidence for the role of neurogenic inflammation components in trypsin-elicited scratching behaviour in mice","volume":"154","author":"Costa","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Liu, Q., Weng, H.J., Patel, K.N., Tang, Z., Bai, H., Steinhoff, M., and Dong, X. (2011). The distinct roles of two GPCRs, MrgprC11 and PAR2, in itch and hyperalgesia. Sci. Signal., 4.","DOI":"10.1126\/scisignal.2001925"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ejphar.2005.11.021","article-title":"Potent pruritogenic action of tryptase mediated by PAR-2 receptor and its involvement in anti-pruritic effect of nafamostat mesilate in mice","volume":"530","author":"Ui","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1248\/bpb.31.752","article-title":"Effects of topical application of tacrolimus on acute itch-associated responses in mice","volume":"31","author":"Nakano","year":"2008","journal-title":"Biol. Pharm. Bull."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jaci.2005.10.033","article-title":"IL-31: A new link between T cells and pruritus in atopic skin inflammation","volume":"117","author":"Sonkoly","year":"2006","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.jaci.2006.07.015","article-title":"Enhanced expression levels of IL-31 correlate with IL-4 and IL-13 in atopic and allergic contact dermatitis","volume":"118","author":"Neis","year":"2006","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.jaci.2008.05.047","article-title":"Correlation of IL-31 serum levels with severity of atopic dermatitis","volume":"122","author":"Raap","year":"2008","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.3389\/fimmu.2019.01383","article-title":"Role of the pruritic cytokine IL-31 in autoimmune skin diseases","volume":"10","author":"Gibbs","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/exd.12222","article-title":"A single dose of interleukin-31 (IL-31) causes continuous itch-associated scratching behaviour in mice","volume":"22","author":"Arai","year":"2013","journal-title":"Exp. Dermatol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jaci.2013.10.048","article-title":"A sensory neuron-expressed IL-31 receptor mediates T helper cell-dependent itch: Involvement of TRPV1 and TRPA1","volume":"133","author":"Cevikbas","year":"2014","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ajhg.2007.09.002","article-title":"Oncostatin M receptor-beta mutations underlie familial primary localized cutaneous amyloidosis","volume":"82","author":"Arita","year":"2008","journal-title":"Am. J. Hum. Genet."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/bjd.14207","article-title":"The first trial of CIM331, a humanized antihuman interleukin-31 receptor A antibody, in healthy volunteers and patients with atopic dermatitis to evaluate safety, tolerability and pharmacokinetics of a single dose in a randomized, double-blind, placebo-controlled study","volume":"174","author":"Nemoto","year":"2016","journal-title":"Br. J. Dermatol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1056\/NEJMoa1606490","article-title":"Anti-interleukin-31 receptor A antibody for atopic dermatitis","volume":"376","author":"Ruzicka","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/ni805","article-title":"Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP","volume":"3","author":"Soumelis","year":"2002","journal-title":"Nat. Immunol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.4049\/jimmunol.1100355","article-title":"Thymic stromal lymphopoietin is produced by dendritic cells","volume":"187","author":"Kashyap","year":"2011","journal-title":"J. Immunol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.ajpath.2012.11.039","article-title":"Protease activity enhances production of thymic stromal lymphopoietin and basophil accumulation in flaky tail mice","volume":"182","author":"Moniaga","year":"2013","journal-title":"Am. J. Pathol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.cell.2013.08.057","article-title":"The epithelial cell-derived atopic dermatitis cytokine TSLP activates neurons to induce itch","volume":"155","author":"Wilson","year":"2013","journal-title":"Cell"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/76923","article-title":"Cloning of a receptor subunit required for signaling by thymic stromal lymphopoietin","volume":"1","author":"Pandey","year":"2000","journal-title":"Nat. Immunol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/B978-0-12-404717-4.00004-4","article-title":"The biology of thymic stromal lymphopoietin (TSLP)","volume":"66","author":"Ziegler","year":"2013","journal-title":"Adv. Pharmacol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.jaci.2010.08.041","article-title":"Mechanical injury polarizes skin dendritic cells to elicit a T(H)2 response by inducing cutaneous thymic stromal lymphopoietin expression","volume":"126","author":"Oyoshi","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.cell.2017.08.006","article-title":"Sensory neurons co-opt classical immune signaling pathways to mediate chronic itch","volume":"171","author":"Oetjen","year":"2017","journal-title":"Cell"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1056\/NEJMoa1314768","article-title":"Dupilumab treatment in adults with moderate-to-severe atopic dermatitis","volume":"371","author":"Beck","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0140-6736(15)00388-8","article-title":"Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: A randomised, placebo-controlled, dose-ranging phase 2b trial","volume":"387","author":"Simpson","year":"2016","journal-title":"Lancet"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.jaad.2018.01.018","article-title":"Baricitinib in adult patients with moderate-to-severe atopic dermatitis: A phase 2 parallel, double-blinded, randomized placebo-controlled multiple-dose study","volume":"80","author":"Silverberg","year":"2019","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.jaad.2018.01.017","article-title":"Efficacy and safety of lebrikizumab (an anti-IL-13 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical corticosteroids: A randomized, placebo-controlled phase II trial (TREBLE)","volume":"78","author":"Simpson","year":"2018","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jaci.2018.05.029","article-title":"Treatment of atopic dermatitis with tralokinumab, an anti-IL-13 mAb","volume":"143","author":"Wollenberg","year":"2019","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1080\/17512433.2018.1507734","article-title":"Adult atopic dermatitis: New and emerging therapies","volume":"11","author":"Napolitano","year":"2018","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s13555-018-0258-x","article-title":"Treatment of atopic dermatitis with biologic drugs","volume":"8","author":"Fabbrocini","year":"2018","journal-title":"Dermatol. Ther."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"e12787","DOI":"10.1111\/dth.12787","article-title":"What\u2019s new in the treatment of atopic dermatitis?","volume":"32","author":"Dattola","year":"2019","journal-title":"Dermatol. Ther."},{"key":"ref_55","unstructured":"Yosipovitch, G. (2004). Substance P and itch. Itch: Basic Mechanisms and Therapy, Dekker."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s00403-002-0378-z","article-title":"Mast cells, nerves and neuropeptides in atopic dermatitis and nummular eczema","volume":"295","author":"Harvima","year":"2003","journal-title":"Arch. Dermatol. Res."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"St\u00e4nder, S., Siepmann, D., Herrgott, I., Sunderk\u00f6tter, C., and Luger, T.A. (2010). Targeting the neurokinin receptor 1 with aprepitant: A novel antipruritic strategy. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0010968"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1001\/archderm.139.11.1479","article-title":"Modern aspects of cutaneous neurogenic inflammation","volume":"139","author":"Steinhoff","year":"2003","journal-title":"Arch. Dermatol."},{"key":"ref_59","first-page":"33","article-title":"Neurogenic inflammation in human and rodent skin","volume":"16","author":"Schmelz","year":"2001","journal-title":"News Physiol. Sci."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/bph.12266","article-title":"The role of histamine in neurogenic inflammation","volume":"170","author":"Rosa","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1152\/physrev.1999.79.4.1193","article-title":"Prostanoid receptors: Structures, properties, and functions","volume":"79","author":"Narumiya","year":"1999","journal-title":"Physiol. Rev."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/exd.13867","article-title":"Transcriptomic and lipidomic profiling of eicosanoid\/docosanoid signalling in affected and non-affected skin of human atopic dermatitis patients","volume":"28","author":"Weise","year":"2019","journal-title":"Exp. Dermatol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1067\/mjd.2002.120462","article-title":"Prostaglandin E2 induces vasodilation and pruritus, but no protein extravasation in atopic dermatitis and controls","volume":"47","author":"Neisius","year":"2002","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1111\/j.1600-0625.2011.01346.x","article-title":"Involvement of leukotriene B4 in spontaneous itch-related behaviour in NC mice with atopic dermatitis-like skin lesions","volume":"20","author":"Andoh","year":"2011","journal-title":"Exp. Dermatol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1038\/sj.jid.5700810","article-title":"Thromboxane A2 induces itch-associated responses through TP receptors in the skin in mice","volume":"127","author":"Andoh","year":"2007","journal-title":"J. Investig. Dermatol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ejphar.2004.10.031","article-title":"Prostanoid DP1 receptor agonist inhibits the pruritic activity in NC\/Nga mice with atopic dermatitis","volume":"505","author":"Arai","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"ref_67","first-page":"265","article-title":"Multiple opioid receptors: Ligand selectivity profiles and binding site signatures","volume":"36","author":"Goldstein","year":"1989","journal-title":"Mol. Pharmacol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1600-0625.2009.00844.x","article-title":"Opioids and the skin--where do we stand?","volume":"18","author":"Bigliardi","year":"2009","journal-title":"Exp. Dermatol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1046\/j.1523-1747.2000.00801.x","article-title":"beta-endorphin stimulates cytokeratin 16 expression and downregulates mu-opiate receptor expression in human epidermis","volume":"114","author":"Bigliardi","year":"2000","journal-title":"J. Investig. Dermatol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0167-0115(02)00159-3","article-title":"Localization of mu-opioid receptor 1A on sensory nerve fibers in human skin","volume":"110","author":"Gunzer","year":"2002","journal-title":"Regul. Pept."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1111\/j.1365-2133.2006.07191.x","article-title":"Transepidermal water loss, serum IgE and beta-endorphin as important and independent biological markers for development of itch intensity in atopic dermatitis","volume":"154","author":"Lee","year":"2006","journal-title":"Br. J. Dermatol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.jaad.2007.01.007","article-title":"Treatment of pruritus with topically applied opiate receptor antagonist","volume":"56","author":"Bigliardi","year":"2007","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/j.1529-8019.2005.00032.x","article-title":"Ultraviolet phototherapy for pruritus","volume":"18","author":"Rivard","year":"2005","journal-title":"Dermatol. Ther."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1111\/exd.14011","article-title":"Is there still a role for UV therapy in itch treatment?","volume":"28","author":"Legat","year":"2019","journal-title":"Exp. Dermatol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1038\/sj.jid.5700942","article-title":"Possible roles of epidermal opioid systems in pruritus of atopic dermatitis","volume":"127","author":"Tominaga","year":"2007","journal-title":"J. Investig. Dermatol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1254\/jphs.FP0070436","article-title":"Development of numerous nerve fibers in the epidermis of hairless mice with atopic dermatitis-like pruritic skin inflammation","volume":"104","author":"Fujii","year":"2007","journal-title":"J. Pharmacol. Sci."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jdermsci.2007.02.002","article-title":"A hypothetical mechanism of intraepidermal neurite formation in NC\/Nga mice with atopic dermatitis","volume":"46","author":"Tominaga","year":"2007","journal-title":"J. Dermatol. Sci."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1586\/edm.10.7","article-title":"Recent advances in pathophysiological mechanisms of itch","volume":"5","author":"Tominaga","year":"2014","journal-title":"Expert Rev. Dermatol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/1346-8138.12317","article-title":"Itch and nerve fibers with special reference to atopic dermatitis: Therapeutic implications","volume":"41","author":"Tominaga","year":"2014","journal-title":"J. Dermatol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1046\/j.1365-2133.2002.04803.x","article-title":"Nerve growth factor and substance P are useful plasma markers of disease activity in atopic dermatitis","volume":"147","author":"Toyoda","year":"2002","journal-title":"Br. J. Dermatol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1468-3083.2007.02399.x","article-title":"The role of selected neuropeptides in pathogenesis of atopic dermatitis","volume":"22","author":"Salomon","year":"2008","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.jaci.2012.05.027","article-title":"Artemin causes hypersensitivity to warm sensation, mimicking warmth-provoked pruritus in atopic dermatitis","volume":"130","author":"Murota","year":"2012","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/ni.3614","article-title":"The aryl hydrocarbon receptor AhR links atopic dermatitis and air pollution via induction of the neurotrophic factor artemin","volume":"18","author":"Hidaka","year":"2017","journal-title":"Nat. Immunol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1111\/j.1365-2133.2007.08410.x","article-title":"Decreased production of semaphorin 3A in the lesional skin of atopic dermatitis","volume":"158","author":"Tominaga","year":"2008","journal-title":"Br. J. Dermatol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"624","DOI":"10.2340\/00015555-2318","article-title":"Possible antipruritic mechanism of cyclosporine A in atopic dermatitis","volume":"96","author":"Ko","year":"2016","journal-title":"Acta Derm. Venereol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/00015550310022899","article-title":"Phototherapy reduces the number of epidermal and CGRP-positive dermal nerve fibres","volume":"84","author":"Wallengren","year":"2004","journal-title":"Acta Derm. Venereol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jdermsci.2009.03.007","article-title":"Psoralen-ultraviolet A therapy alters epidermal Sema3A and NGF levels and modulates epidermal innervation in atopic dermatitis","volume":"55","author":"Tominaga","year":"2009","journal-title":"J. Dermatol. Sci."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1038\/jid.2014.256","article-title":"The excimer lamp induces cutaneous nerve degeneration and reduces scratching in a dry-skin mouse model","volume":"134","author":"Kamo","year":"2014","journal-title":"J. Investig. Dermatol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.2340\/00015555-3296","article-title":"Skin barrier damage and itch: Review of mechanisms, topical management and future directions","volume":"99","author":"Yosipovitch","year":"2019","journal-title":"Acta Derm. Venereol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1038\/jid.2010.143","article-title":"Injury to the stratum corneum induces in vivo expression of human thymic stromal lymphopoietin in the epidermis","volume":"130","author":"Fernandez","year":"2010","journal-title":"J. Investig. Dermatol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1046\/j.1523-1747.1998.00364.x","article-title":"Low humidity stimulates epidermal DNA synthesis and amplifies the hyperproliferative response to barrier disruption: Implication for seasonal exacerbations of inflammatory dermatoses","volume":"111","author":"Denda","year":"1998","journal-title":"J. Investig. Dermatol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1254\/jjp.88.285","article-title":"Itch-associated response induced by experimental dry skin in mice","volume":"88","author":"Miyamoto","year":"2002","journal-title":"Jpn. J. Pharmacol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"645","DOI":"10.2340\/00015555-1834","article-title":"Surfactant-induced chronic pruritus: Role of L-histidine decarboxylase expression and histamine production in epidermis","volume":"94","author":"Inami","year":"2014","journal-title":"Acta Derm. Venereol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.pain.2010.07.024","article-title":"Enhanced scratching evoked by PAR-2 agonist and 5-HT but not histamine in a mouse model of chronic dry skin itch","volume":"151","author":"Akiyama","year":"2010","journal-title":"Pain"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.neuroscience.2014.02.005","article-title":"Behavioral model of itch, alloknesis, pain and allodynia in the lower hindlimb and correlative responses of lumbar dorsal horn neurons in the mouse","volume":"266","author":"Akiyama","year":"2014","journal-title":"Neuroscience"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1097\/j.pain.0000000000000439","article-title":"Toll-like receptor 4 contributes to chronic itch, alloknesis, and spinal astrocyte activation in male mice","volume":"157","author":"Liu","year":"2016","journal-title":"Pain"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.molimm.2003.10.005","article-title":"Innate immunity: An overview","volume":"40","author":"Beutler","year":"2004","journal-title":"Mol. Immunol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1111\/exd.13314","article-title":"Friends or Foes? Host defense (antimicrobial) peptides and proteins in human skin diseases","volume":"26","author":"Niyonsaba","year":"2017","journal-title":"Exp. Dermatol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1111\/cea.12843","article-title":"The role of human beta-defensins in allergic diseases","volume":"46","author":"Niyonsaba","year":"2016","journal-title":"Clin. Exp. Allergy"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1056\/NEJMoa021481","article-title":"Endogenous antimicrobial peptides and skin infections in atopic dermatitis","volume":"347","author":"Ong","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1111\/j.0022-202X.2005.23935.x","article-title":"High expression levels of keratinocyte antimicrobial proteins in psoriasis compared with atopic dermatitis","volume":"125","author":"Zeeuwen","year":"2005","journal-title":"J. Investig. Dermatol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.4049\/jimmunol.171.6.3262","article-title":"Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes","volume":"171","author":"Nomura","year":"2003","journal-title":"J. Immunol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/j.0022-202X.2005.23776.x","article-title":"Interleukin-10 downregulates anti-microbial peptide expression in atopic dermatitis","volume":"125","author":"Howell","year":"2005","journal-title":"J. Investig. Dermatol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1084\/jem.20061308","article-title":"Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides","volume":"203","author":"Liang","year":"2006","journal-title":"J. Exp. Med."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1038\/jid.2014.143","article-title":"Host defense (Antimicrobial) peptide, human beta-defensin-3, improves the function of the epithelial tight-junction barrier in human keratinocytes","volume":"134","author":"Kiatsurayanon","year":"2014","journal-title":"J. Investig. Dermatol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1159\/000362789","article-title":"The human cathelicidin LL-37 host defense peptide upregulates tight junction-related proteins and increases human epidermal keratinocyte barrier function","volume":"6","author":"Akiyama","year":"2014","journal-title":"J. Innate Immun."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1111\/bjd.13125","article-title":"The antimicrobial protein S100A7\/psoriasin enhances the expression of keratinocyte differentiation markers and strengthens the skin\u2019s tight junction barrier","volume":"171","author":"Hattori","year":"2014","journal-title":"Br. J. Dermatol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1038\/jid.2015.243","article-title":"Cathelicidin LL-37 induces semaphorin 3A expression in human epidermal keratinocytes: Implications for possible application to pruritus","volume":"135","author":"Umehara","year":"2015","journal-title":"J. Investig. Dermatol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jdermsci.2017.07.010","article-title":"Antimicrobial peptides human LL-37 and beta-defensin-3 modulate the expression of nerve elongation factors in human epidermal keratinocytes","volume":"88","author":"Umehara","year":"2017","journal-title":"J. Dermatol. Sci."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1002\/1521-4141(200104)31:4<1066::AID-IMMU1066>3.0.CO;2-#","article-title":"Evaluation of the effects of peptide antibiotics human beta-defensins-1\/-2 and LL-37 on histamine release and prostaglandin D(2) production from mast cells","volume":"31","author":"Niyonsaba","year":"2001","journal-title":"Eur. J. Immunol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1002\/eji.200636379","article-title":"Antimicrobial peptides human beta-defensin (hBD)-3 and hBD-4 activate mast cells and increase skin vascular permeability","volume":"37","author":"Chen","year":"2007","journal-title":"Eur. J. Immunol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"3526","DOI":"10.4049\/jimmunol.0900712","article-title":"Antimicrobial peptides human beta-defensins and cathelicidin LL-37 induce the secretion of a pruritogenic cytokine IL-31 by human mast cells","volume":"184","author":"Niyonsaba","year":"2010","journal-title":"J. Immunol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.imbio.2011.10.010","article-title":"Increased serum human beta-defensin-2 levels in atopic dermatitis: Relationship to IL-22 and oncostatin M","volume":"217","author":"Kanda","year":"2012","journal-title":"Immunobiology"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/bjd.12419","article-title":"Human beta-defensin-2 as a marker for disease severity and skin barrier properties in atopic dermatitis","volume":"169","author":"Clausen","year":"2013","journal-title":"Br. J. Dermatol."}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/9\/3\/229\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:28:08Z","timestamp":1760160488000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/9\/3\/229"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,25]]},"references-count":114,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,3]]}},"alternative-id":["biomedicines9030229"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines9030229","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,25]]}}}